Mark Mallon Net Worth & Insider Trades
Mark Mallon - Chief Executive Officer, Neogenomics Inc
What is Mark Mallon's Net Worth?
The current estimated net worth of Neogenomics Inc's Chief Executive Officer, Mark Mallon, is estimated to be about $4.79M . Mark Mallon owns about 72,736 units of Neogenomics Inc common stock. In the last year at Neogenomics Inc, Mark Mallon has sold an estimated value of $0 worth.
What is Mark Mallon's Past Insider Trading?
Mark Mallon's largest purchase order was 17,000 units , worth over $520.71K on December 6, 2021. In total, Mark Mallon has made about 4 transactions over a year of their time at Neogenomics Inc. Mark Mallon usually trades in December, with the busiest year in 2021.
Mark Mallon
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Mark Mallon's' Mailing Address?
- Mailing address is C/o Ironwood Pharmaceuticals, Inc. 100 Summer Street, Suite 2300 Boston MA 02110 MA
Neogenomics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|---|
| Douglas M. VanOort | 2020 | $669,039 | - | $990,000 | - | - | - | $3,000 | $4,122,039 |
| Douglas M. VanOort | 2019 | $665,000 | - | $742,507 | - | - | - | $3,000 | $3,648,732 |
| Douglas M. VanOort | 2018 | $641,923 | - | $650,006 | - | - | - | $3,000 | $3,347,219 |
| Kathryn B. McKenzie | 2020 | $359,616 | - | $165,000 | - | - | - | - | $1,034,616 |
| Kathryn B. McKenzie | 2019 | $250,000 | - | $44,551 | - | - | - | - | $524,844 |
| Kathryn B. McKenzie | 2018 | - | - | - | - | - | - | - | - |
| Sharon A. Virag | 2020 | - | - | - | - | - | - | - | - |
| Sharon A. Virag | 2019 | $257,723 | - | $214,502 | - | - | - | - | $1,041,645 |
| Sharon A. Virag | 2018 | $298,462 | $120,000 | - | - | - | - | - | $1,093,562 |
| Robert J. Shovlin | 2020 | $404,808 | - | $247,500 | - | - | - | $3,000 | $1,297,308 |
| Robert J. Shovlin | 2019 | $400,000 | - | $214,502 | - | - | - | $3,000 | $1,284,099 |
| Robert J. Shovlin | 2018 | $375,385 | - | - | - | - | - | $3,000 | $1,328,739 |
| Douglas M. Brown | 2020 | $346,154 | - | $198,000 | - | - | - | $100,000 | $1,246,154 |
| Douglas M. Brown | 2019 | - | - | - | - | - | - | - | - |
| Douglas M. Brown | 2018 | - | - | - | - | - | - | - | - |
| Dr. Lawrence M. Weiss | 2020 | $600,000 | - | $165,000 | - | - | - | - | $1,285,000 |
| Dr. Lawrence M. Weiss | 2019 | $600,000 | - | $115,503 | - | - | - | - | $1,183,674 |
| Dr. Lawrence M. Weiss | 2018 | $571,519 | $100,000 | - | - | - | - | - | $855,895 |
| No matching records found | |||||||||
Source: https://www.sec.gov/Archives/edgar/data/1077183/000119312521117812/d62762ddef14a.htm
What are Neogenomics Inc's Past Insider Trades?
Neogenomics Inc's most recent insider trade came on March 9, 2022 by William Bonello who sold 3,209 units worth $58.69K . In the last 9 years, insiders at Neogenomics Inc have sold an estimated value of $380.32M and bought an estimated value of $34.93M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Steven Jones, Director, Douglas M. Vanoort, Director, and Jennifer Balliet, VP and Chief Culture Officer .
NEOGENOMICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||